Investors & Media

Welcome to the Investor Relations and Public Relations division of Medigene AG. This is where you will find current information on a variety of subjects, including Medigene AG shares, company news, financial reports and key figures.

Latest News

Medigene Receives $3 Million Milestone Payment from 2seventy bio


Medigene Announces Strategy and Corporate Update


Medigene presents new data on reproducible production of TCR-T cells from MDG1011 program


The Medigene Share

The Medigene share MDG1 (ISIN:DE000A1X3W00 ) is listed at the Frankfurt Stock Exchange since June 2000. 

show medigene share


29 Mar 2023

Annual Report 2022

03 May 2023

Quarterly Statement Q1 2023

02 Aug 2023

6-Months Report 2023

10 Aug 2023

Annual General Meeting 2023

26 Oct 2023

Quarterly Statement Q3 2023

Corporate Governance

Good corporate governance is the basis of our decision-making and monitoring processes. It stands for responsible and value-based leadership and control of the Company for long-term success, goal-oriented and efficient cooperation between the Executive Board and Supervisory Board, respect for the interests of our shareholders and employees, consistently transparent and responsible corporate decisions and an appropriate risk management system.

read more

press photos

Laboratory work

DownLoad (9 MB)

Laboratory work (6)

Cell culture work

DownLoad (4 MB)

Laboratory work (7)

Cell sorting

DownLoad (353 KB)

Contact person

Phone: +49 89 2000 3333 01
Fax: +49 89 2000 33 2920